Table 1 Demographic variables at day 0 for the 3 treatment groups and comparison across groups
Variable | Firocoxib | PCSO-524 | Combination | P value |
|---|---|---|---|---|
Number of dogs | 24 | 27 | 28 | |
Severity of clinical sign | 0.929 | |||
- Mild to moderate | 18 | 19 | 20 | |
- Severe | 6 | 8 | 8 | |
Body weight ± SD (kg) | 34.82 ± 6.62 | 37.53 ± 8.55 | 35.77 ± 6.13 | 0.394 |
Age ± SD (years) | 4.46 ± 2.89 | 5.44 ± 3.18 | 4.18 ± 2.88 | 0.267 |
Body condition score | 0.284 | |||
- 1/5 | 0 | 0 | 1 | |
- 2/5 | 1 | 0 | 0 | |
- 3/5 | 12 | 11 | 11 | |
- 4/5 | 10 | 9 | 13 | |
- 5/5 | 1 | 7 | 3 | |
Breed | 0.457 | |||
- Golden retriever | 13 | 13 | 17 | |
- Labrador retriever | 6 | 10 | 7 | |
- Siberian husky | 3 | 0 | 2 | |
- Crossbreed | 2 | 1 | 0 | |
- Bangkeaw | 0 | 1 | 0 | |
- Cane corso | 0 | 1 | 0 | |
- American pitbull | 0 | 1 | 2 | |
Sex | 0.926 | |||
- Male | 9 | 11 | 12 | |
- Female | 15 | 16 | 16 | |
Joint affected | 0.171 | |||
- Hip | 20 | 20 | 26 | |
- Hip and Stifle | 4 | 7 | 2 | |
Side of affected joint | 0.582 | |||
- Unilateral | 1 | 0 | 1 | |
- Bilateral | 23 | 27 | 27 | |
Side of affected limb | 0.899 | |||
- Left | 14 | 17 | 16 | |
- Right | 10 | 10 | 12 | |
Duration of signs (months) | 13.46 ± 13.82 | 14.07 ± 10.84 | 12.75 ± 13.19 | 0.927 |
OAS | 5.42 ± 2.70 | 6.59 ± 2.99 | 5.43 ± 2.28 | 0.188 |
CBPI | 1.62 ± 1.29 | 2.23 ± 1.97 | 1.62 ± 1.65 | 0.310 |
PVF (%BW) | 64.79 ± 5.98 | 62.01 ± 6.85 | 59.97 ± 9.38 | 0.081 |